Somalia has reached a major milestone in pharmaceutical governance following the enactment of Law No. 55 of 2026, establishing the
Nairobi, Kenya – Cabinet Secretary for Health Hon. Aden Duale chaired a consultative meeting with the Pharmacy and Poisons Board
The Pharmacy and Poisons Board and Zambia Medicines Regulatory Authority are discussing a memorandum of understanding to strengthen capacity building for assessors, inspectors and scientists.
The Pharmacy and Poisons Board will require GS1-compliant unit-level serialization from 1 January 2027, building on batch-level traceability already under way for locally manufactured and imported products.
The Pharmacy and Poisons Board has introduced marketing authorisation renewal, strengthened inspections and enhanced pharmacy practice standards, and is advancing product authentication and traceability systems.
The Agence béninoise du Médicament et des autres produits de Santé and the Agence Nationale de Transfusion Sanguine have updated the national reporting form for adverse events linked to labile blood products.
The Agence Marocaine du Médicament et des Produits de Santé has signed a partnership agreement with the Institut Marocain de Normalisation to strengthen collaboration on standards, certification and conformity assessment for medicines and medical products.
Nigeria’s National Agency for Food and Drug Administration and Control has prohibited pesticides containing paraquat, chlorpyrifos and atrazine after completing a phased regulatory review, while restricting small-pack Dichlorvos over misuse concerns.
The Tanzania Medicines and Medical Devices Authority has reminded all registrants and marketing authorisation holders of their obligation to submit biennial post-marketing surveillance reports for registered medical devices and in vitro diagnostics.
The National Agency for Food and Drug Administration and Control (NAFDAC) joins the global community in celebrating the United Nations